CarsonAllaria Wealth Management Ltd. trimmed its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 15.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 737 shares of the company’s stock after selling 134 shares during the period. CarsonAllaria Wealth Management Ltd.’s holdings in Procter & Gamble were worth $124,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AMF Tjanstepension AB raised its position in Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Czech National Bank raised its holdings in shares of Procter & Gamble by 6.6% in the 3rd quarter. Czech National Bank now owns 479,545 shares of the company’s stock worth $83,057,000 after buying an additional 29,799 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Procter & Gamble by 10.0% during the 3rd quarter. Versant Capital Management Inc now owns 2,720 shares of the company’s stock worth $471,000 after buying an additional 247 shares during the period. Chapin Davis Inc. boosted its stake in Procter & Gamble by 10.1% in the 3rd quarter. Chapin Davis Inc. now owns 16,100 shares of the company’s stock valued at $2,788,000 after buying an additional 1,479 shares in the last quarter. Finally, Eastover Investment Advisors LLC grew its position in Procter & Gamble by 3.9% in the third quarter. Eastover Investment Advisors LLC now owns 44,226 shares of the company’s stock valued at $7,660,000 after acquiring an additional 1,654 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $168.16 on Wednesday. The firm has a market capitalization of $394.32 billion, a P/E ratio of 26.78, a PEG ratio of 3.73 and a beta of 0.45. The business has a 50-day moving average of $168.17 and a 200-day moving average of $169.41. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1 year low of $153.52 and a 1 year high of $180.43.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.39%. Procter & Gamble’s payout ratio is 64.17%.
Insiders Place Their Bets
In related news, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the sale, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 151,097 shares of company stock worth $25,635,076 over the last ninety days. 0.18% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on PG shares. JPMorgan Chase & Co. reduced their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a research note on Thursday, January 16th. Morgan Stanley boosted their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. DA Davidson reiterated a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Thursday, January 23rd. Barclays increased their price target on Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 23rd. Finally, Wells Fargo & Company boosted their price objective on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a research note on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $180.53.
Check Out Our Latest Stock Report on PG
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Basic Materials Stocks Investing
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Using the MarketBeat Stock Split Calculator
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- P/E Ratio Calculation: How to Assess Stocks
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.